Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Nov;34(5):509–515. doi: 10.1038/bjc.1976.205

Hepatitis B surface antigen produced by a human hepatoma cell line.

G M MacNab, J J Alexander, G Lecatsas, E M Bey, J M Urbanowicz
PMCID: PMC2025201  PMID: 187208

Abstract

The human hepatoma cell line, PLC/PRF/5, was shown to produce hepatitis B surface antigen (HBsAg). Immunologically reactive material was present in the supernatant tissue culture medium in significant amounts, and was associated with spherical particles approximately 20 nm in diameter. The rate of antigen production by the cells was estimated at 500 ng/day/10(6) cells by reference to a purified HBsAg standard. All immunological activity was neutralized by specific antibody and the subtype was ad. The studies reported here broaden the scope of investigations on both the in vitro production of HBsAg and the association between this antigen and primary liver cancer.

Full text

PDF
509

Images in this article

513Fig. 2
on p.513

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander J., Bey E., Whitcutt J. M., Gear J. H. Adaptation of cells derived from human malignant tumours to growth in vitro. S Afr J Med Sci. 1976;41(2):89–98. [PubMed] [Google Scholar]
  2. Bey E., Alexander J., Whitcutt J. M., Hunt J. A., Gear J. H. Carcinoma of the esophagus in Africans: establishment of a continuously growing cell line from a tumor specimen. In Vitro. 1976 Feb;12(2):107–114. doi: 10.1007/BF02796356. [DOI] [PubMed] [Google Scholar]
  3. Coyne V. E., Blumberg B. S., Millman I. Detection of Australia antigen in human tissue culture preparations. Proc Soc Exp Biol Med. 1971 Dec;138(3):1051–1057. doi: 10.3181/00379727-138-36048. [DOI] [PubMed] [Google Scholar]
  4. Dane D. S., Cameron C. H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970 Apr 4;1(7649):695–698. doi: 10.1016/s0140-6736(70)90926-8. [DOI] [PubMed] [Google Scholar]
  5. Dreesman G. R., Hollinger F. B., Melnick J. L. Biophysical and biochemical properties of purified preparations of hepatitis B surface antigen (HBs Ag). Am J Med Sci. 1975 Jul-Aug;270(1):123–129. doi: 10.1097/00000441-197507000-00018. [DOI] [PubMed] [Google Scholar]
  6. EPSTEIN M. A., ACHONG B. G., BARR Y. M. VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet. 1964 Mar 28;1(7335):702–703. doi: 10.1016/s0140-6736(64)91524-7. [DOI] [PubMed] [Google Scholar]
  7. Howard C. R., Zuckerman A. J. Characterization of hepatitis B antigen polypeptides. Intervirology. 1974;4(1):31–44. doi: 10.1159/000149841. [DOI] [PubMed] [Google Scholar]
  8. Ling C. M., Overby L. R. Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody. J Immunol. 1972 Oct;109(4):834–841. [PubMed] [Google Scholar]
  9. Panous-Perrin J., Rachman F., Courouce-Pauty A. M., Dupuy J. M. Culture of hepatitis B virus on a human cell line of hepatic origin. Preliminary results. Biomedicine. 1973 Oct 10;19(10):442–446. [PubMed] [Google Scholar]
  10. Robinson W. S., Clayton D. A., Greenman R. L. DNA of a human hepatitis B virus candidate. J Virol. 1974 Aug;14(2):384–391. doi: 10.1128/jvi.14.2.384-391.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vogel C. L., Anthony P. P., Mody N., Barker L. F. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet. 1970 Sep 26;2(7674):621–624. doi: 10.1016/s0140-6736(70)91396-6. [DOI] [PubMed] [Google Scholar]
  12. Zuckerman A. J. Tissue and organ culture studies of hepatitis B virus. Am J Med Sci. 1975 Jul-Aug;270(1):197–204. doi: 10.1097/00000441-197507000-00027. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES